title: Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy.
abstract: BACKGROUND
  Hepatitis C virus (HCV)/HIV co-infected patients have more rapid progression of liver fibrosis and only modest cure rates (sustained virologic responses, SVRs) when compared to HCV monoinfected patients.
  
  
  METHODS
  We compared the virologic responses of either twice-weekly peginterferon-α-2a 180 μg/week (for 4 weeks, followed by weekly dosing) or weekly peginterferon-α-2a 180 μg/week, and weight-based ribavirin (1-1.2 g/day), among HIV/HCV co-infected genotype-1 individuals.
  
  
  RESULTS
  Patients receiving the investigational dosing had lower levels of HCV RNA at all time points after initiation of therapy. More patients on this arm achieved clinically relevant early virological responses at weeks 1, 2, 4, 12, and 24. The enhanced early virologic response observed with the investigational arm was associated with a higher induction of interferon-stimulated genes. This early double dose regimen also resulted in a rapid normalization of liver enzymes. Twice-weekly peginterferon-α-2a was associated with more frequent early virological responses with similar safety profiles when compared with standard therapy.
  
  
  CONCLUSIONS
  Our results, when confirmed in larger randomized clinical trials, may provide a novel therapeutic approach to improve SVR among HIV/HCV co-infected patients, especially African-American patients.
authors: LIR, NIAID, NIH, DHHS, Bethesda, Maryland, USA.
authors: Alison A
authors: AA
authors: Murphy
authors: Eva
authors: E
authors: Herrmann
authors: Anu O
authors: AO
authors: Osinusi
authors: Lynn
authors: L
authors: Wu
authors: William
authors: W
authors: Sachau
authors: Richard A
authors: RA
authors: Lempicki
authors: Jun
authors: J
authors: Yang
authors: Tje L
authors: TL
authors: Chung
authors: Tei L
authors: TL
authors: Chung
authors: Brad J
authors: BJ
authors: Wood
authors: Bart L
authors: BL
authors: Haagmans
authors: Shyam
authors: S
authors: Kottilil
authors: Michael A
authors: MA
authors: Polis
references: Nature. 2004 Dec 16;432(7019):922-4
references: 15602565
references: Clin Infect Dis. 2003 Apr 15;36(8):1030-8
references: 12684916
references: Hepatology. 2006 May;43(5):943-53
references: 16761329
references: Clin Infect Dis. 2002 Mar 15;34(6):831-7
references: 11833007
references: N Engl J Med. 2004 Jul 29;351(5):451-9
references: 15282352
references: Hepatology. 2009 Jul;50(1):34-45
references: 19551908
references: Scand J Gastroenterol. 2002 Feb;37(2):226-32
references: 11843062
references: JAMA. 2004 Dec 15;292(23):2839-48
references: 15598915
references: Hepatology. 2009 Oct;50(4):1045-55
references: 19676125
references: N Engl J Med. 2004 Jul 29;351(5):438-50
references: 15282351
references: Clin Infect Dis. 2003 Feb 15;36(4):491-8
references: 12567308
references: Hepatology. 2007 Jul;46(1):16-21
references: 17596864
references: N Engl J Med. 2009 Aug 6;361(6):580-93
references: 19625712
references: J Acquir Immune Defic Syndr. 2002 Apr 1;29(4):378-87
references: 11917243
references: Hepatology. 1999 Oct;30(4):1054-8
references: 10498659
references: J Infect Dis. 2006 Apr 15;193(8):1172-7
references: 16544259
references: J Hepatol. 2005 Sep;43(3):425-33
references: 15990196
references: N Engl J Med. 2002 Sep 26;347(13):975-82
references: 12324553
references: Hepatology. 2003 Jun;37(6):1351-8
references: 12774014
references: Expert Opin Drug Metab Toxicol. 2009 Mar;5(3):321-32
references: 19331594
references: J Infect Dis. 2003 Nov 15;188(10):1498-507
references: 14624375
references: Lancet. 2001 Sep 22;358(9286):958-65
references: 11583749
references: J Viral Hepat. 2002 Sep;9(5):334-9
references: 12225327
references: Hepatology. 2003 Jun;37(6):1257-9
references: 12774002
references: AIDS. 2003 May 2;17(7):1023-8
references: 12700452
references: J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):103-13
references: 14722440
references: Gastroenterology. 2006 Aug;131(2):470-7
references: 16890601
references: AIDS. 2009 Nov 27;23(18):2439-50
references: 19898214
references: AIDS. 2007 Sep 12;21(14):1855-65
references: 17721093